Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Midyear 2026 Check in: Abzena’s Campbell Bunce on Trends in Antibody Drug Conjugates

ByCampbell Bunce,Susan Haigney

July 23rd 2026

Saharsh Davuluri's Midyear Take on the Shifting CDMO Landscape Covers Out-Licensing, Agility, and Investment Surprises

BySaharsh Davuluri

July 22nd 2026

Ask the Expert: Drug Approval Submissions

BySusan J. Schniepp,Siegfried Schmitt,Susan Haigney

July 22nd 2026

Brent Wilhelm, Senior Vice President of Global Supply Chain, Cencora

Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs

ByBrent Wilhelm,Zachary Zubulake

July 22nd 2026

Six Months Later: Neuland's Saharsh Davuluri Checks In on India, AI, and API Manufacturing

BySaharsh Davuluri

July 21st 2026

E-Procurement  Reverse Auctions and the Supplier's Perspective

Articles in this issue

Related Content

Midyear 2026 Check in: Abzena’s Campbell Bunce on Trends in Antibody Drug Conjugates

Saharsh Davuluri's Midyear Take on the Shifting CDMO Landscape Covers Out-Licensing, Agility, and Investment Surprises

Ask the Expert: Drug Approval Submissions

Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs

Six Months Later: Neuland's Saharsh Davuluri Checks In on India, AI, and API Manufacturing

Trending on Pharmaceutical Technology

Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data

Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs

Ask the Expert: Drug Approval Submissions

Everything to Know about BMS & NVidia’s AI Supercomputer

PharmTech Weekly Roundup—July 17, 2026

E-Procurement &#151; Reverse Auctions and the Supplier's Perspective

Articles in this issue

Related Content

Midyear 2026 Check in: Abzena’s Campbell Bunce on Trends in Antibody Drug Conjugates

Saharsh Davuluri's Midyear Take on the Shifting CDMO Landscape Covers Out-Licensing, Agility, and Investment Surprises

Ask the Expert: Drug Approval Submissions

Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs

Six Months Later: Neuland's Saharsh Davuluri Checks In on India, AI, and API Manufacturing

Trending on Pharmaceutical Technology

Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data

Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs

Ask the Expert: Drug Approval Submissions

Everything to Know about BMS & NVidia’s AI Supercomputer

PharmTech Weekly Roundup—July 17, 2026

E-Procurement Reverse Auctions and the Supplier's Perspective